Celyad Sa Stock Fundamentals
| CYAD Stock | EUR 0.65 0.04 5.80% |
Celyad SA fundamentals help investors to digest information that contributes to Celyad SA's financial success or failures. It also enables traders to predict the movement of Celyad Stock. The fundamental analysis module provides a way to measure Celyad SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celyad SA stock.
Celyad |
Celyad SA Company Shares Outstanding Analysis
Celyad SA's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Celyad SA Shares Outstanding | 22.59 M |
Most of Celyad SA's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celyad SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Celyad SA has 22.59 M of shares currently outstending. This is 87.48% lower than that of the Biotechnology sector and 78.86% lower than that of the Health Care industry. The shares outstanding for all Belgium stocks is 96.05% higher than that of the company.
Celyad SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Celyad SA's current stock value. Our valuation model uses many indicators to compare Celyad SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celyad SA competition to find correlations between indicators driving Celyad SA's intrinsic value. More Info.Celyad SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Celyad SA's earnings, one of the primary drivers of an investment's value.Celyad Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celyad SA's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celyad SA could also be used in its relative valuation, which is a method of valuing Celyad SA by comparing valuation metrics of similar companies.Celyad SA is currently under evaluation in shares outstanding category among its peers.
Celyad Fundamentals
| Return On Equity | -0.93 | |||
| Return On Asset | -0.29 | |||
| Current Valuation | 11.19 M | |||
| Shares Outstanding | 22.59 M | |||
| Shares Owned By Insiders | 8.83 % | |||
| Shares Owned By Institutions | 24.19 % | |||
| Price To Earning | (22.41) X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 22,298 X | |||
| Gross Profit | 5 K | |||
| EBITDA | (24.73 M) | |||
| Net Income | (26.51 M) | |||
| Cash And Equivalents | 12.13 M | |||
| Cash Per Share | 0.85 X | |||
| Total Debt | 3.4 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 1.42 X | |||
| Book Value Per Share | 1.36 X | |||
| Cash Flow From Operations | (26.64 M) | |||
| Earnings Per Share | (1.44) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 95 | |||
| Beta | 1.76 | |||
| Market Capitalization | 28.29 M | |||
| Total Asset | 79.94 M | |||
| Working Capital | 97.93 M | |||
| Current Asset | 109.42 M | |||
| Current Liabilities | 11.49 M | |||
| Z Score | 6.0 | |||
| Net Asset | 79.94 M |
About Celyad SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celyad SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celyad SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celyad SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor-T cell-based therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. CELYAD ONCOLOGY operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 87 people.
Pair Trading with Celyad SA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Celyad SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celyad SA will appreciate offsetting losses from the drop in the long position's value.Moving against Celyad Stock
| 0.79 | BNB | Banque nationale | PairCorr |
| 0.71 | CFEB | Compagnie d Entreprises Earnings Call Today | PairCorr |
| 0.65 | BEKB | NV Bekaert SA | PairCorr |
The ability to find closely correlated positions to Celyad SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Celyad SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Celyad SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Celyad SA to buy it.
The correlation of Celyad SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Celyad SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Celyad SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Celyad SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Celyad Stock Analysis
When running Celyad SA's price analysis, check to measure Celyad SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celyad SA is operating at the current time. Most of Celyad SA's value examination focuses on studying past and present price action to predict the probability of Celyad SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celyad SA's price. Additionally, you may evaluate how the addition of Celyad SA to your portfolios can decrease your overall portfolio volatility.